Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025;25(11):774-784.
doi: 10.2174/0118715206336788241029050155.

Anti-metastasis Effects and Mechanism of Action of Curcumin Analog (2E,6E)-2,6-bis(2,3-dimethoxybenzylidene) Cyclohexanone (DMCH) on the SW620 Colorectal Cancer Cell Line

Nurul Fattin Che Rahim  1 , Yazmin Hussin  1 , Muhammad Nazirul Mubin Aziz  2 , Mas Jaffri Masarudin  1   3 , Shafinaz Abd Gani  4 , Muhammad Nadeem Akhtar  5 , Nik Mohd Afizan Nik Abd Rahman  1 , Noorjahan Banu Alitheen  1   3
Affiliations

Anti-metastasis Effects and Mechanism of Action of Curcumin Analog (2E,6E)-2,6-bis(2,3-dimethoxybenzylidene) Cyclohexanone (DMCH) on the SW620 Colorectal Cancer Cell Line

Nurul Fattin Che Rahim et al. Anticancer Agents Med Chem. 2025.

Abstract

Background: Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths. Curcumin has been reported to have suppressive effects in CRC and to address the physiological limitations of curcumin, a chemically synthesized curcuminoid analog, known as (2E,6E)-2,6-Bis (2,3-Dimethoxy benzylidine) cyclohexanone (DMCH), was developed and the anti-metastatic and anti-angiogenic properties of DMCH in colorectal cell line, SW620 were examined.

Methods: The anti-metastatic effects of DMCH were examined in the SW620 cell line by scratch assay, migration, and invasion assay, while for anti-angiogenesis properties of the cells, the mouse aortic ring assay and Human Umbilical Vein Endothelial Cells (HUVEC) assay were conducted. The mechanism of action was determined by microarray-based gene expression and protein analyses.

Results: The wound healing assay demonstrated that wound closure was decreased from 63.63 ± 1.44% at IC25 treatment to 4.54 ± 0.62% at IC50 treatment. Significant (p < 0.05) reductions in the percentage of migrated and invaded cells were also observed in SW620, with values of 36.39 ± 3.86% and 44.81 ± 3.54%, respectively. Mouse aortic ring assays demonstrated a significant reduction in the formation of tubes and microvessels. Microarray and protein profiler results revealed that DMCH treatment has modulated several metastases, angiogenesisrelated transcripts, and proteins like Epidermal Growth Factor Receptor (EGFR), TIMP-1 (TIMP Metallopeptidase Inhibitor 1) and Vascular Endothelial Growth Factor (VEGF).

Conclusion: DMCH could be a potential anti-cancer agent due to its capability to impede metastasis and angiogenesis activities of the SW620 colorectal cancer cell line in vitro via regulating genes and protein in metastases and angiogenesis-related signalling pathways.

Keywords: Colon cancer; DMCH; angiogenesis; curcumin analog; epidermal growth factor receptor (EGFR).; metastasis.

PubMed Disclaimer

References

    1. Wong M.C.S.; Huang J.; Lok V.; Wang J.; Fung F.; Ding H.; Zheng Z.J.; Differences in incidence and mortality trends of colorectal cancer worldwide based on sex, age, and anatomic location. Clin Gastroenterol Hepatol 2021,19(5),955-966.e61 - DOI - PubMed
    1. Keum N.; Giovannucci E.; Global burden of colorectal cancer: Emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol 2019,16(12),713-732 - DOI - PubMed
    1. Schliemann D.; Paramasivam D.; Dahlui M.; Cardwell C.R.; Somasundaram S.; Ibrahim Tamin N.S.B.; Donnelly C.; Su T.T.; Donnelly M.; Change in public awareness of colorectal cancer symptoms following the be cancer alert campaign in the multi-ethnic population of Malaysia. BMC Cancer 2020,20(1),252 - DOI - PubMed
    1. National strategic plan for colorectal cancer 2021-2025 Available from: https://www.moh.gov.my/moh/resources/Penerbitan/Rujukan/NCD/Kanser/Natio... Cancer_(NSPCRC)_2021-2025.pdf2021
    1. Morgan E.; Arnold M.; Gini A.; Lorenzoni V.; Cabasag C.J.; Laversanne M.; Vignat J.; Ferlay J.; Murphy N.; Bray F.; Global burden of colorectal cancer in 2020 and 2040: Incidence and mortality estimates from GLOBOCAN. Gut 2023,72(2),338-344 - DOI - PubMed

MeSH terms